Abstract. Embryonic stem (ES) cells hold promise for cell and tissue replacement approaches to treating human diseases. However, long-term in vitro culture and manipulations of ES cells may adversely affect their epigenetic integrity including imprinting. Disruption or inappropriate expression of imprinted genes is associated with several clinically significant syndromes and tumorigenesis in humans. We demonstrated aberrant biallelic expression of IGF2 and H19 in several rhesus monkey ES cell lines while SNRPN and NDN were normally imprinted and expressed from the paternal allele. In contrast, expanded blastocyst-stage embryos, from which these ES cells were derived, exhibited normal paternal expression of IGF2 and maternal expression of H19. To test the possibility that aberrant methylation at an imprinting centre (IC) upstream of H19 accounts for the relaxed imprinting of IGF2 and H19, we performed comprehensive methylation analysis by investigating methylation profiles of CpG sites within the IGF2/H19 IC. Our results demonstrate abnormal hypermethylation within the IGF2/H19 IC in all analysed ES cell lines consistent with biallelic expression of these genes. Cellular overproliferation and tumour formation resulting from tissue or cell transplantation are potential problems that must be addressed before clinical trials of ES cell-based therapy are initiated.
Introduction
Mammalian development originates from a single cell, the zygote, which upon cleavage gives rise to a few totipotent cells of the early embryo. These totipotent cells eventually proliferate and differentiate into a wide variety of cell phenotypes that are found in adult bodies. During differentiation, cells become increasingly restricted in their developmental potential, with most cells terminally differentiating and becoming locked into a single fate. The complex pattern of gene expression governing development and differentiation is tightly regulated by epigenetic modifications, i.e. modifications of chromatin not involving changes in the DNA sequence. Epigenetic modifications are post-synthetic modifications of either DNA itself or proteins that are closely associated with DNA as key mediators. These events seem to be interpreted by proteins that recognise a particular modification and facilitate the appropriate downstream biological effects. Well known examples of epigenetic modifications are DNA methylation as well as some modification of histones including methylation and acetylation. DNA methylation is responsible for stable gene expression patterns. Commonly, DNA methylation is associated with a silent chromatin state. DNA methylation in mammalian systems is found in cytosine in the context of CpG dinucleotides. CpG dinucleotides are relatively underrepresented in the mammalian genome compared with other dinucleotide types. However, CpGs tend to cluster in the genome in so-called 'CpG islands'. The role of DNA methylation has been increasingly studied lately because of its association with cancer development since many cancer cells contain hypermethylated DNA, which in turn can lead to the silencing of tumour suppressor genes by promoter methylation. Epigenetic errors can arise either randomly or, very often, under the influence of the environment and in humans are associated with severe developmental syndromes and cancer.
Imprinting during early development
Genomic imprinting is the form of epigenetic modification of chromatin that leads to either absolute or preferential expression of specific parental alleles. Imprinting is controlled in part by DNA methylation and possibly by other chromatin modifications that lead to silencing of maternal or paternal alleles and subsequent monoallelic expression. Imprinting must be reprogrammed during germline development, which first involves erasure of epigenetic marks during early germ-cell development and establishment later of new imprints in a sex-specific manner. There are ∼50 or so known imprinted genes in humans and most of them appear in clusters. Two intensively studied imprinting clusters that have been implicated in human disease are located on chromosome 11p15.5 known as the Beckwith-Wiedemann syndrome (BWS) region and the Prader-Willi syndrome/Angelman syndrome (PWS/AS) region located on 15q11-q13. Imprinting in these regions is controlled by so-called imprinting centers (ICs) that regulate parent-specific expression of target genes bidirectionally over long distances. The mechanism by which ICs regulate expression of targeted genes is poorly understood, however, it is well known that these ICs harbour CpG islands that are differentially methylated depending on parental origin. Methylation of CpG dinucleotides within ICs is proposed to be one of the initial mechanisms differentially marking parental chromosomes in gametes. Once established, locus-specific DNA methylation profiles must be stably maintained in future generations of cells.
Why are we interested in imprinted gene expression in preimplantation embryos and embryonic stem (ES) cells? As I mentioned, disruption or inappropriate expression of imprinted genes is associated with several syndromes in humans. Moreover, in adults, imprinting errors are associated with cancer and tumour development. Imprinted genes are known to be particularly susceptible to epigenetic alterations during in vitro manipulations. For example, there is strong evidence suggesting that alterations in H19 expression often result from embryo exposure to suboptimal culture conditions (Doherty et al. 2000; Khosla et al. 2001; Mann et al. 2003) . There are also suggestions that the abnormal morphologies often observed in cloned animals are a consequence of abnormal expression of imprinted genes (Mann et al. 2003) . In humans, assisted reproductive technologies, specifically intracytoplasmic sperm injection, are linked to increased incidence of imprinting disorders including BWS and AS (DeBaun et al. 2003; Maher et al. 2003) . Last but not least, it has been demonstrated that mouse ES cells acquire unstable expression of H19, Igf2 and Igf2r during in vitro culture (Dean et al. 1998) . Thus, it is important to address concerns over imprinting integrity in ES cells, as well as in preimplantation embryos used as a routine source for ES cell isolation before transplantation trials. Because of numerous ethical, legal and practical limitations on human embryo and ES cell research, we believe that non-human primates represent the ideal model system in which allele-specific expression and methylation of imprinted genes can be examined. In the rhesus monkey, gametes, preimplantation-stage embryos and ES cells are readily available and moreover, their properties are very similar to those of humans.
Imprinting in the rhesus monkey
Our main objective is to gain insights into the timing and stability of imprint establishment during early primate development. More specifically, we focused on the analysis of allele-specific expression of four imprinted genes: H19, IGF2, SNRPN and NDN. First, we analysed the imprinted status of these genes in monkey embryos produced by assisted reproductive technologies. Next, we extended our studies to monkey ES cell lines derived from these in vitro-produced embryos with respect to their potential use in regenerative medicine. IGF2 is paternally expressed and encodes for mitogenic peptide, whereas H19 is maternally expressed encoding untranslated RNA. Both play important roles in the control of embryonic and placental growth and are physically located on human chromosome 11p15. Loss of IGF2 and/or H19 imprinting is associated with BWS, Wilms' tumours, bladder and colon cancers and osteosarcoma. NDN and SNRPN are both paternally expressed genes and encode neurally differentiated embryonal carcinoma-cell derived factor and small nuclear ribonucleoprotein N, involved in mRNA splicing, respectively. Both genes are located on human chromosome 15q11-q13 and loss of imprinting is associated with the developmental neurobehavioural disorder known as PWS. The choice of these two genes was predicated on some indication that at least initial imprints that control paternally expressed genes in PWS region are not established during gamete development in humans (El-Maarri et al. 2001) . It was suggested that imprints in this region are established during fertilisation, post-fertilisation or even in post-implantation development (El-Maarri et al. 2001) . We hypothesised that in vitro embryo production and more specifically ES cell derivation procedures may interfere with normal patterns of imprinting establishment.
Main prerequisites for the allele-specific expression analysis of imprinted genes are the presence of polymorphic alleles and generation of heterozygous embryos and ES cell lines. Despite the fact that the rhesus monkey is widely used in biomedical research, little genetic information is available when it comes to DNA sequence and genome organisation in this species. Therefore, during the initial stages of this project we focused on defining polymorphisms in the form of single nucleotide polymorphisms (SNPs) within coding regions of these four genes. Fortunately, because of the close genetic similarities between humans and rhesus monkeys, we were able efficiently utilise human GenBank sequence information to design primers for amplification and sequencing of monkey gDNA. Next, we screened coding regions for these four imprinted and one non-imprinted (control) genes in over a hundred rhesus females and males and identified 23 SNPs that we used for allele-specific expression analysis in embryos and stem cells (Fujimoto et al. 2005) . The idea was to create a database on distribution of useful alleles in our rhesus monkey colony and then use this database to select and match males and females carrying different alleles to generate heterozygous embryos and subsequently ES cell lines.
The first question we addressed was whether these four imprinted genes that we selected are indeed imprinted in rhesus monkeys. We identified four juvenile monkeys produced by natural breeding that were heterozygous and detected expressed parental allelles by reverse transcriptionpolymerase chain reaction (RT-PCR) and direct sequencing in the muscle tissue. All four imprinted genes, including IGF2, H19, SNRPN and NDN, were expressed from a single allele whereas non-imprinted GAPD was expressed from both alleles (Table 1 ) (Fujimoto et al. 2005) . Unfortunately, we did not have parental information for these animals so we could only confirm the monoallelic expression of these genes. However, we identified five heterozygous infants produced in our laboratory by intracytoplasmic sperm injection (ICSI) from known parents. We were able to show that IGF2, NDN and SNRPN were also normally imprinted in these infants and expressed from paternal alleles whereas the H19 expression was from the maternal allele (Table 1) . These results confirmed that four genes of interest are imprinted in the monkey and the imprinting pattern is similar to mice and humans. Next, we addressed the question of whether imprints are stable in embryos produced by assisted reproductive technology (ART) procedures, specifically by ICSI. We used gametes from males and females carrying different alleles of the same gene or if such animals were unavailable, we used heterozygous and homozygous monkeys to produce informative heterozygous embryos. Embryos were cultured to the blastocyst stage in vitro (7-8 days) and used for DNA and RNA harvesting and direct sequencing following PCR amplification. We confirmed the heterozygosity by genomic DNA and then using RT-PCR we analysed what allele was expressed. SNRPN was expressed as expected from the paternal allele at the blastocyst stage (Table 2) (Fujimoto et al. 2006) . Similarly, we confirmed that IGF2 was also normally imprinted and expressed from paternal alleles, and the H19 from maternal alleles (Table 2) . Surprisingly, NDN was not imprinted and predominantly expressed from both alleles and in few cases from the maternal allele. We analysed a large number of embryos and in 22 out of 27 cases expression was from both alleles ( Table 2 ). In summary, at least three of these genes, including two that were expected to be prone to alterations due to in vitro embryo culture, were normally imprinted in monkey blastocysts produced by ARTs. Despite evidence that culture conditions may dramatically impact imprinted expression of H19 and IGF2 in the mouse, this conclusion could not be extrapolated to primates based on the present study.
In the case of NDN, there are two scenarios that could explain non-imprinted gene expression. One is that the in vitro embryo production used in our studies may have caused this abnormality. Another explanation is that NDN is naturally not imprinted at this stage of development in the monkey, and our subsequent observations that this gene was imprinted in ES cells derived from blastocysts suggests that it was simply a matter of timing and imprinting had not yet been established in the Day 7-9 blastocyst. If that is the case, we present the first evidence that imprinted expression of some genes is delayed and established during the late preimplantation or even post-implantation stages of development.
Next, we analysed the imprinting status of these genes in rhesus monkey ES cell lines derived from ART-produced embryos. To date, we have established 22 cell lines from ICSI -or conventional in vitro-produced blastocysts. All cell lines have been characterised for expression of well defined pluripotency markers as well as by differentiation potential in vitro and in vivo into teratomas. We first analysed eight ES cell lines (ORMES series) for the presence of SNPs based on their parental origin. Four cell lines were informative for NDN that was paternally expressed in all ES cell lines, suggesting that, in striking contrast to embryos, the imprinting here was normal (Table 2) (Fujimoto et al. 2006) . SNRPN was also normally imprinted and paternally expressed in three informative ORMES cell lines. However IGF2 lost its imprinting and in five informative ES cell lines was biallelically expressed (Table 2 ). We applied quantitative RT-PCR and confirmed that IGF2 was expressed equally from both maternal and paternal alleles. H19 was also abnormally biallelically expressed in three cell lines. We then examined whether this pattern of imprinting in ES cells is retained in differentiated phenotypes such as neuronal cells. We found that the pattern of expression of these four genes was maintained in ES cell-derived differentiated populations (Table 2 ). In summary, in monkey ES cells NDN and SNRPN were normally imprinted, but we believe that IGF2 and H19 lost their imprinting and were biallelically expressed.
Imprinting in human embryonic stem cells
What is the imprinted status of IGF2 and H19 in human ES cell lines? We acquired two human ES cell lines at relatively early passages from the National Institute of Health (NIH) registry (BGN2 from BresaGen and H1 from WiCell) and screened for the presence of SNPs within coding regions. We found two adjacent G/A SNPs within exon 5 of H19 in BGN2 at nucleotide positions #10736 and #10739, GenBank accession no. AF087017. Using RT-PCR followed by direct sequencing, we found that H19 was monoallelically expressed in undifferentiated BGN2 at passages 35 and 38. Moreover, the same pattern of expression was retained in differentiated progeny. H1 cells contained a C/T SNP within exon 9 of IGF2 that enabled us to conduct allele-specific expression analysis in this human ES cell line. In undifferentiated H1 cells and differentiated phenotypes including neural progenitors and contracting cardiomyocytes, IGF2 was predominantly expressed monoallelically. Our results are in agreement with a recent study in which monoallelic expression of IGF2 and H19 was also described for three other heterozygous human ES cell lines (Rugg-Gunn et al. 2005) . This suggests that, in contrast to mouse and to monkeys, human ES cells maintain a substantial degree of epigenetic stability at least in these two genes. However, more extensive propagation of one human ES cell line to over 90 passages resulted in the activation of the previously silent allele and biallelic expression of H19 (Rugg-Gunn et al. 2005) .
Loss of imprinting generally correlates with the abnormal maintenance of methylation patterns at corresponding ICs. To address this hypothesis, we conducted detailed methylation studies using genomic bisulfite sequencing. Specifically, we focused on the common IC that reciprocally regulates imprinted expression of both H19 and IGF2. We amplified the monkey IC ∼2 kb upstream of H19 that contained two CpG islands and confirmed that this region is differentially methylated in skeletal muscle tissue, consistent with monoallelic expression of H19 and IGF2. Similar to the mouse and human, all analysed maternal clones were unmethylated whereas paternal clones were heavily methylated in this tissue. In monkey ES cell lines, we detected various degrees of abnormal methylation of maternal clones within the IGF2/H19 IC, thus potentially accounting for the observed biallelic expression of both IGF2 and H19.
Future studies
In ongoing and future studies, we are addressing the question: what specific factors result in aberrant imprinting in monkey ES cells? We are particularly interested in the effect of ES cell culture and medium conditions, such as serum supplementation and hyperoxia (oxidative stress due to high concentration of oxygen), on the stability of imprinting. Another future goal is to investigate the consequences of transplantation of specific phenotypes derived from monkey ES cells with abnormal imprinting into a recipient.
